Trials in diabetic foot ulcer using autologous fobroblast-seeded collagen substitutes

Trials in diabetic foot ulcer using autologous fobroblast-seeded collagen substitutes - Trials in diabetic foot ulcer using autologous fobroblast-seeded collagen substitutes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001518

Enrollment

Registered

2008-12-01

Start date

2008-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic foot ulcer

Interventions

implantation of autologous fibroblast-seded substitute

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient's ulcer is on the leg or foot Patient's ulcer has been present for a minimum of 1 month SPP (Skin Perfusion Pressure) at the proximal margin or distal margin of patient's ulcer is more than 25mmHg.

Exclusion criteria

Exclusion criteria: Patient's ulcer is with extensive exposure of tendon or bone

Design outcomes

Primary

Measure	Time frame
Improvement of wound bed 3 weeks after implantation	—

Countries

Japan

Contacts

Public ContactNaoki Morimoto

Kyoto University department of Plastic and Reconstructive surgery

0757514460

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026